VPS18 and glioblastoma: By harnessing the biological characteristics of VPS18, synergistic drugs could potentially be developed in combination with BIBF in the future, thereby enhancing therapeutic effects on glioblastoma, particularly through targeting the autophagy pathway, which is especially crucial.